Source map — US FDA approves Asahi Kasei's drug for persistent herpes infections
Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.
| Source | Type | Trust |
|---|---|---|
| Reuters | news | 60% |
| Dealroom | news | 60% |
| PharmTech.com | news | 60% |
| Healio | news | 60% |
| FirstWord Pharma | news | 60% |
| Business Wire | news | 60% |
| Mugglehead Investment Magazine | news | 60% |
| Moomoo | news | 60% |
| www.dermatologytimes.com | news | 50% |
| srnnews.com | news | 50% |
| www.rttnews.com | news | 50% |
| www.biospace.com | news | 50% |
| www.infectiousdiseaseadvisor.com | news | 50% |
| www.pharmajournalist.com | news | 50% |
| gxpnews.net | news | 50% |
| business.optum.com | news | 50% |
| skinailab.com | news | 50% |
| medcitynews.com | news | 50% |
| www.asahi-kasei.com | news | 50% |
| news.geobrowser.io | news | 50% |
| www.taylorvilledailynews.com | news | 50% |
| consent.yahoo.com | news | 50% |
| pharma.economictimes.indiatimes.com | news | 50% |
| www.empr.com | news | 50% |
| www.yahoo.com | news | 50% |